Could a diabetes drug help breast cancer survivors shed pounds?
NCT ID NCT07257484
First seen Dec 11, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looks at whether tirzepatide, a once-weekly injection, is a practical and acceptable treatment for weight loss in 30 postmenopausal women who have had hormone receptor-positive breast cancer and are currently obese. Participants will take the medication for 6 months with monthly check-ins, and the researchers will track weight, body fat, blood sugar, and overall health. The goal is to see if this approach can help manage obesity and improve well-being in this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
New York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.